| 发明名称 |
METHODS AND COMPOSITIONS FOR TREATMENT OF DISORDERS AMELIORATED BY MUSCARINIC RECEPTOR ACTIVATION |
| 摘要 |
Methods for the treatment of CNS disorders using combinations of muscarinic activators and inhibitors, and medicaments comprising muscarinic activators and inhibitors. |
| 申请公布号 |
US2017112820(A1) |
申请公布日期 |
2017.04.27 |
| 申请号 |
US201715400108 |
申请日期 |
2017.01.06 |
| 申请人 |
PureTech Health LLC |
发明人 |
Elenko Eric;Murray, III Philip E.;Miller Andrew C. |
| 分类号 |
A61K31/46;A61K9/48;A61K31/4439 |
主分类号 |
A61K31/46 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A medicament comprising a muscarinic Activator, a muscarinic Inhibitor, and a pharmaceutically acceptable carrier, wherein the muscarinic Activator is xanomeline and the muscarinic Inhibitor is trospium chloride. |
| 地址 |
Boston MA US |
